ALHC
HoldFallen FavouriteAlignment Healthcare, Inc. · Healthcare · United States · $2.8B · Avg Vol: $61M/d
Fallen Favourite: A good business that is expensive and falling. Wait for the price to catch up.
ABOUT ALIGNMENT HEALTHCARE, INC.
Read
Alignment Healthcare, Inc. is a tech-enabled Medicare Advantage health plan company focused on delivering integrated and personalized healthcare to seniors. Its competitive moat is derived from its proprietary data analytics platform, AVA, which optimizes care coordination and supports a value-based care model. The company is a growing niche player disrupting traditional healthcare by enhancing member experience and improving health outcomes.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 1.4B | 1.8B | 2.7B | 3.9B | 40.2% | 4.6B | 5.2B | 6.5B | 28.3% |
| EPS | -1.14 | -0.83 | -0.79 | -0.67 | 0.00 | — | 0.19 | — | — | — |
| Shares | — | 187.3M | 189.0M | 191.8M | 204.2M | +9.0% | 207.4M | — | — | — |
| Debt | — | 164.6M | 170.8M | 329.3M | 329.6M | 26.0% | 330.5M | — | — | — |
| Equity | — | 238.1M | 156.9M | 99.9M | 179.3M | -9.0% | — | — | — | — |
| Op CF | — | -45.4M | -59.2M | 34.8M | 139.9M | 302.4% | 205.5M | — | — | — |
| Inv CF | — | -28.2M | -147.3M | 39.2M | -15.0M | — | — | — | — | — |
| Fin CF | — | 16.6M | 0.1M | 156.0M | 18.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ALHC are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ALHC | Alignment Healthcare, Inc.(you) | $2.8B | 59 | Hold |
| CLOV | Clover Health Investments, Corp. | $2.2B | 79 | Buy |
| MOH | Molina Healthcare, Inc. | $10.4B | 71 | Buy |
| PGNY | Progyny, Inc. | $2.0B | 98 | Strong Buy |
| OSCR | Oscar Health, Inc. | $9.4B | 98 | Strong Buy |
| CNC | Centene Corporation | $32.0B | 93 | Strong Buy |
| HUM | Humana Inc. | $46.3B | 89 | Strong Buy |
| CI | The Cigna Group | $73.7B | 92 | Strong Buy |
| ELV | Elevance Health, Inc. | $85.5B | 90 | Strong Buy |
| ACHC | Acadia Healthcare Company, Inc. | $2.7B | 59 | Hold |
Peer medians: ROE -31.0% · P/E 25.0x · Gross margin 58.3%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.